These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33276102)

  • 1. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain.
    Ruiz-Cantero MC; González-Cano R; Tejada MÁ; Santos-Caballero M; Perazzoli G; Nieto FR; Cobos EJ
    Pharmacol Res; 2021 Jan; 163():105339. PubMed ID: 33276102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
    Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.
    Sánchez-Fernández C; Entrena JM; Baeyens JM; Cobos EJ
    Adv Exp Med Biol; 2017; 964():109-132. PubMed ID: 28315268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma-1 receptors and animal studies centered on pain and analgesia.
    Davis MP
    Expert Opin Drug Discov; 2015; 10(8):885-900. PubMed ID: 26037105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.
    Merlos M; Burgueño J; Portillo-Salido E; Plata-Salamán CR; Vela JM
    Adv Exp Med Biol; 2017; 964():85-107. PubMed ID: 28315267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain.
    Denaro S; Pasquinucci L; Turnaturi R; Alberghina C; Longhitano L; Giallongo S; Costanzo G; Spoto S; Grasso M; Zappalà A; Li Volti G; Tibullo D; Vicario N; Parenti R; Parenti C
    Mol Neurobiol; 2024 May; 61(5):2672-2685. PubMed ID: 37922065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists.
    Tejada MÁ; Montilla-García Á; González-Cano R; Bravo-Caparrós I; Ruiz-Cantero MC; Nieto FR; Cobos EJ
    Pharmacol Res; 2018 May; 131():224-230. PubMed ID: 29454675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 receptor targeting inhibits connexin 43 based intercellular communication in chronic neuropathic pain.
    Denaro S; D'Aprile S; Torrisi F; Zappalà A; Marrazzo A; Al-Khrasani M; Pasquinucci L; Vicario N; Parenti R; Parenti C
    Inflamm Res; 2024 Oct; 73(10):1711-1726. PubMed ID: 39095656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats.
    Gris G; Portillo-Salido E; Aubel B; Darbaky Y; Deseure K; Vela JM; Merlos M; Zamanillo D
    Sci Rep; 2016 Apr; 6():24591. PubMed ID: 27087602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects.
    Romero L; Merlos M; Vela JM
    Adv Pharmacol; 2016; 75():179-215. PubMed ID: 26920013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigma 1 receptor: a new therapeutic target for pain.
    Zamanillo D; Romero L; Merlos M; Vela JM
    Eur J Pharmacol; 2013 Sep; 716(1-3):78-93. PubMed ID: 23500210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain.
    Donnelly CR; Andriessen AS; Chen G; Wang K; Jiang C; Maixner W; Ji RR
    Neurotherapeutics; 2020 Jul; 17(3):846-860. PubMed ID: 32820378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.
    Gao YJ; Ji RR
    Pharmacol Ther; 2010 Apr; 126(1):56-68. PubMed ID: 20117131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
    Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
    Romero L; Zamanillo D; Nadal X; Sánchez-Arroyos R; Rivera-Arconada I; Dordal A; Montero A; Muro A; Bura A; Segalés C; Laloya M; Hernández E; Portillo-Salido E; Escriche M; Codony X; Encina G; Burgueño J; Merlos M; Baeyens JM; Giraldo J; López-García JA; Maldonado R; Plata-Salamán CR; Vela JM
    Br J Pharmacol; 2012 Aug; 166(8):2289-306. PubMed ID: 22404321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?
    Cairns BE; Arendt-Nielsen L; Sacerdote P
    Scand J Pain; 2015 Jan; 6(1):3-6. PubMed ID: 29911589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte sigma-1 receptors modulate connexin 43 expression leading to the induction of below-level mechanical allodynia in spinal cord injured mice.
    Choi SR; Roh DH; Yoon SY; Kwon SG; Choi HS; Han HJ; Beitz AJ; Lee JH
    Neuropharmacology; 2016 Dec; 111():34-46. PubMed ID: 27567941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement.
    Di Cesare Mannelli L; Cinci L; Micheli L; Zanardelli M; Pacini A; McIntosh JM; Ghelardini C
    Pain; 2014 Oct; 155(10):1986-95. PubMed ID: 25008370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma-1 receptor antagonists: promising players in fighting neuropathic pain.
    Linciano P; Rossino G; Listro R; Rossi D; Collina S
    Pharm Pat Anal; 2020 May; 9(3):77-85. PubMed ID: 32539668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.